Kornitzer Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.1M Buy
1,417,822
+60,507
+4% +$1.58M 0.71% 33
2026
Q1
$38.1M Buy
1,357,315
+115,759
+9% +$3.08M 0.82% 31
2025
Q4
$30.9M Sell
1,241,556
-5,209
-0.4% -$131K 0.64% 34
2025
Q3
$31.8M Buy
1,246,765
+2,115
+0.2% +$52.2K 0.64% 34
2025
Q2
$30.2M Sell
1,244,650
-41,708
-3% -$973K 0.61% 37
2025
Q1
$32.6M Buy
1,286,358
+76,349
+6% +$2M 0.67% 32
2024
Q4
$32.1M Buy
1,210,009
+41,694
+4% +$1.13M 0.63% 35
2024
Q3
$33.8M Buy
1,168,315
+27,562
+2% +$804K 0.62% 34
2024
Q2
$31.9M Sell
1,140,753
-51,962
-4% -$1.43M 0.61% 33
2024
Q1
$33.1M Buy
1,192,715
+8,457
+0.7% +$235K 0.61% 34
2023
Q4
$34.1M Buy
1,184,258
+587
+0% +$17.7K 0.66% 32
2023
Q3
$39.3M Buy
1,183,671
+13,044
+1% +$461K 0.81% 22
2023
Q2
$42.9M Buy
1,170,627
+20,346
+2% +$792K 0.84% 23
2023
Q1
$46.9M Buy
1,150,281
+12,254
+1% +$529K 0.94% 17
2022
Q4
$58.3M Sell
1,138,027
-1,905
-0.2% -$91.3K 1.18% 14
2022
Q3
$49.9M Sell
1,139,932
-18,483
-2% -$898K 1.07% 15
2022
Q2
$60.7M Sell
1,158,415
-3,220
-0.3% -$164K 1.21% 7
2022
Q1
$60.1M Sell
1,161,635
-38,648
-3% -$2.01M 0.99% 11
2021
Q4
$70.9M Sell
1,200,283
-11,035
-0.9% -$547K 1.06% 6
2021
Q3
$52.1M Sell
1,211,318
-1,869
-0.2% -$82.8K 0.8% 14
2021
Q2
$47.5M Buy
1,213,187
+822
+0.1% +$32K 0.71% 19
2021
Q1
$43.9M Buy
1,212,365
+14,344
+1% +$509K 0.7% 24
2020
Q4
$44.1M Sell
1,198,021
-73,036
-6% -$2.68M 0.75% 21
2020
Q3
$44.3M Sell
1,271,057
-1,834
-0.1% -$64.3K 0.87% 16
2020
Q2
$39.5M Buy
1,272,891
+38,100
+3% +$1.29M 0.8% 18
2020
Q1
$38.2M Sell
1,234,791
-1,957
-0.2% -$66.7K 0.91% 13
2019
Q4
$46M Sell
1,236,748
-14,911
-1% -$531K 0.81% 19
2019
Q3
$42.7M Sell
1,251,659
-14,671
-1% -$533K 0.78% 25
2019
Q2
$52M Sell
1,266,330
-1,392
-0.1% -$55.3K 0.92% 15
2019
Q1
$51.1M Buy
1,267,722
+2,281
+0.2% +$91.3K 0.92% 15
2018
Q4
$52.4M Sell
1,265,441
-13,896
-1% -$577K 1.05% 8
2018
Q3
$53.5M Sell
1,279,337
-7,567
-0.6% -$291K 0.85% 20
2018
Q2
$44.3M Sell
1,286,904
-791
-0.1% -$27K 0.74% 26
2018
Q1
$43.4M Buy
1,287,695
+34,798
+3% +$1.2M 0.74% 27
2017
Q4
$43.1M Sell
1,252,897
-7,136
-0.6% -$243K 0.73% 25
2017
Q3
$42.7M Sell
1,260,033
-9,449
-0.7% -$304K 0.74% 30
2017
Q2
$40.5M Sell
1,269,482
-36,142
-3% -$1.14M 0.71% 30
2017
Q1
$42.4M Buy
1,305,624
+24,348
+2% +$768K 0.75% 27
2016
Q4
$39.5M Buy
1,281,276
+19,318
+2% +$590K 0.74% 30
2016
Q3
$40.6M Buy
1,261,958
+51,054
+4% +$1.71M 0.73% 27
2016
Q2
$40.5M Buy
1,210,904
+215,083
+22% +$6.86M 0.73% 28
2016
Q1
$28M Buy
995,821
+115,003
+13% +$3.28M 0.48% 71
2015
Q4
$27M Buy
880,818
+20,544
+2% +$646K 0.44% 73
2015
Q3
$25.6M Buy
860,274
+1,755
+0.2% +$56.3K 0.41% 90
2015
Q2
$27.3M Buy
858,519
+23,420
+3% +$763K 0.37% 98
2015
Q1
$27.6M Buy
835,099
+3,819
+0.5% +$121K 0.33% 101
2014
Q4
$24.6M Buy
831,280
+54,477
+7% +$1.56M 0.29% 110
2014
Q3
$21.8M Buy
776,803
+90,553
+13% +$2.54M 0.25% 117
2014
Q2
$19.3M Buy
686,250
+32,129
+5% +$916K 0.21% 132
2014
Q1
$19.9M Buy
654,121
+15,498
+2% +$462K 0.21% 136
2013
Q4
$18.6M Sell
638,623
-2,613
-0.4% -$76K 0.2% 140
2013
Q3
$17.5M Buy
641,236
+30,887
+5% +$840K 0.2% 131
2013
Q2
$16.2M Buy
+610,349
New +$16.9M 0.21% 137

Other funds holding PFE

Kornitzer Capital Management's PFE Position: Q2 2026 in Review

Kornitzer Capital Management increased its Pfizer (PFE) stake by 4.5% in Q2 2026, buying an estimated $1.58M and bringing the position to 1,417,822 shares worth $34.1M. The position accounts for 0.71% of the portfolio, ranked #33.

Kornitzer Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $70.9M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Kornitzer Capital Management held 1,417,822 shares of Pfizer worth $34.1M as of Q2 2026.
  • Kornitzer Capital Management bought 60,507 Pfizer shares in Q2 2026, an estimated $1.58M.
  • Pfizer made up 0.71% of Kornitzer Capital Management's portfolio in Q2 2026, its #33 holding.
  • Kornitzer Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Kornitzer Capital Management's Pfizer position peaked at $70.9M in Q4 2021.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.